274 related articles for article (PubMed ID: 29402878)
21. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ
Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
[TBL] [Abstract][Full Text] [Related]
22. Comparable outcomes in intestinal retransplantation: Single-center cohort study.
Ekser B; Kubal CA; Fridell JA; Mangus RS
Clin Transplant; 2018 Jul; 32(7):e13290. PubMed ID: 29782661
[TBL] [Abstract][Full Text] [Related]
23. Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection.
Abdel-Azim H; Mahadeo KM; Zhao Q; Khazal S; Kohn DB; Crooks GM; Shah AJ; Kapoor N
Am J Hematol; 2015 Nov; 90(11):1021-6. PubMed ID: 26242764
[TBL] [Abstract][Full Text] [Related]
24. Small bowel transplantation in infants and children.
Kocoshis SA
Gastroenterol Clin North Am; 1994 Dec; 23(4):727-42. PubMed ID: 7698829
[TBL] [Abstract][Full Text] [Related]
25. Graft-versus-host disease after intestinal and multivisceral transplantation.
Wu G; Selvaggi G; Nishida S; Moon J; Island E; Ruiz P; Tzakis AG
Transplantation; 2011 Jan; 91(2):219-24. PubMed ID: 21076376
[TBL] [Abstract][Full Text] [Related]
26. Fifteen years' experience of intestinal and multivisceral transplantation in the Nordic countries.
Varkey J; Simrén M; Jalanko H; Oltean M; Saalman R; Gudjonsdottir A; Gäbel M; Borg H; Edenholm M; Bentdal O; Husby S; Staun M; Mäkisalo H; Bosaeus I; Olausson M; Pakarinen M; Herlenius G
Scand J Gastroenterol; 2015 Mar; 50(3):278-90. PubMed ID: 25592555
[TBL] [Abstract][Full Text] [Related]
27. Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.
Taylor E; Jones M; Hourigan MJ; Johnson DW; Gill DS; Isbel N; Hawley CM; Marlton P; Gandhi MK; Campbell SB; Mollee P
Nephrol Dial Transplant; 2015 Oct; 30(10):1774-9. PubMed ID: 26188340
[TBL] [Abstract][Full Text] [Related]
28. Current status of small bowel and multivisceral transplantation.
Vianna RM; Mangus RS; Tector AJ
Adv Surg; 2008; 42():129-50. PubMed ID: 18953814
[TBL] [Abstract][Full Text] [Related]
29. Intestinal transplantation in composite visceral grafts or alone.
Todo S; Tzakis AG; Abu-Elmagd K; Reyes J; Nakamura K; Casavilla A; Selby R; Nour BM; Wright H; Fung JJ
Ann Surg; 1992 Sep; 216(3):223-33; discussion 233-4. PubMed ID: 1384443
[TBL] [Abstract][Full Text] [Related]
30. Graft versus host disease after multivisceral transplantation: A UK center experience and update on management.
Sharkey LM; Peacock S; Russell NK; Middleton SJ; Butler AJ
Clin Transplant; 2018 May; 32(5):e13239. PubMed ID: 29543344
[TBL] [Abstract][Full Text] [Related]
31. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
Hale G; Jacobs P; Wood L; Fibbe WE; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H
Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
[TBL] [Abstract][Full Text] [Related]
33. Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.
Timpone JG; Yimen M; Cox S; Teran R; Ajluni S; Goldstein D; Fishbein T; Kumar PN; Matsumoto C
Transpl Infect Dis; 2016 Apr; 18(2):202-9. PubMed ID: 26853894
[TBL] [Abstract][Full Text] [Related]
34. [Small intestine transplantation. Experimental and clinical results].
Panis Y; Valleur P
Ann Chir; 1993; 47(7):645-58. PubMed ID: 7504899
[TBL] [Abstract][Full Text] [Related]
35. A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.
Abu-Elmagd KM; Costa G; Bond GJ; Soltys K; Martin L; Koritsky DA; Cunha-Melo JR; Sogawa H; Irish W; Tzakis A; Mazariegos G
Clin Transpl; 2012; ():155-66. PubMed ID: 23721018
[TBL] [Abstract][Full Text] [Related]
36. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
[TBL] [Abstract][Full Text] [Related]
37. Ninety-five cases of intestinal transplantation at the University of Miami.
Nishida S; Levi D; Kato T; Nery JR; Mittal N; Hadjis N; Madariaga J; Tzakis AG
J Gastrointest Surg; 2002; 6(2):233-9. PubMed ID: 11992809
[TBL] [Abstract][Full Text] [Related]
38. Imaging findings in children with proliferative disorders following multivisceral transplantation.
Hryhorczuk AL; Kim HB; Harris MH; Vargas SO; Zurakowski D; Lee EY
Pediatr Radiol; 2015 Jul; 45(8):1138-45. PubMed ID: 25796382
[TBL] [Abstract][Full Text] [Related]
39. Intestinal Transplantation: Include the Spleen with Intestinal Graft?
Matsumoto R; Kato T
Gastroenterol Clin North Am; 2024 Jun; 53(2):281-288. PubMed ID: 38719378
[TBL] [Abstract][Full Text] [Related]
40. Clinical presentation and outcomes of norovirus infection in intestinal allograft compared to native intestine.
Florescu DF; Sonderup JL; Grant W; Chong PP; van Duin D; Kalil AC
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
